Diagnoptics News

What's new?

Read all news items about the AGE Reader and Diagnoptics.

DiagnOptics receives Health Canada approval for Diab-spot

Groningen, the Netherlands – May 1, 2012
DiagnOptics has received approval from Health Canada for the Diab-spot. This allows the Canadian distributor of the Diab-spot, Bescot Healthcare, to also start the sale of the Diab-spot in Canada besides the already available AGE Reader.

This approval means entry to another important market for DiagnOptics: the diabetes screening market in Canada. Diab-spot offers a noninvasive and convenient method for diabetes screening with an immediate screening result on the spot.

Share this link on:

Latest news items

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The 'AGE Reader mu' is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.